

Interim results from Oxford Pharmascience show the first small signs of an exciting future after it morphed into a drug re-development company. Group...


Oxford Pharmascience, a speciality pharmaceutical company, has successfully completed the formulation development for its Safestat drugs, Atorvastatin...